✦ LIBER ✦

Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast Cancer

✍ Scribed by Gorshein, Elan; Klein, Paula; Boolbol, Susan K.; Shao, Theresa

Book ID: 122255734
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 262 KB
Volume: 14
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2014.02.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathological Axillary Lymph Node Status

Pathological Axillary Lymph Node Status in HER-2 Receptor Positive and Negative Breast Cancers

✍ Jeon Hor Chen; Garima Agrawal; P. Carpenter; Rita S. Mehta; Orhan Nalcioglu; Min 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 146 KB

The clinicopathologic characteristics an

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

✍ Jiyoung Rhee; Sae-Won Han; Do-Youn Oh; Jee Hyun Kim; Seock-Ah Im; Wonshik Han; I 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 344 KB

Prognostic significance of triple negati

Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller

✍ H.W. Lai; S.J. Kuo; L.S. Chen; C.W. Chi; S.T. Chen; T.W. Chang; D.R. Chen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Differences in metastatic potential in H

Differences in metastatic potential in HER2 positive and triple negative inflammatory breast cancer

✍ Daniela Kolarevic; Zorica Tomasevic 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Adjuvant trastuzumab with chemotherapy i

Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer

✍ Heather L. McArthur; Kathleen M. Mahoney; Patrick G. Morris; Sujata Patil; Linds 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 1 views

## Abstract ## BACKGROUND: Several large, randomized trials established the benefits of adjuvant trastuzumab with chemotherapy. However, the benefit for women with small, node‐negative HER2‐positive (HER2+) disease is unknown, as these patients were largely excluded from these trials. Therefore, a

Hydrophobic Proteome Analysis of Triple

Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer

✍ Ming Lu; Stephen A. Whelan; Jianbo He; Romaine E. Saxton; Kym F. Faull; Julian P 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 217 KB